Involvement of NLRP3 inflammasome in rituximab-induced interstitial lung disease: a case report.
about
A Case of Interstitial Lung Disease Probably Related to Rituximab Treatment.Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin's lymphoma.Biologics-induced interstitial lung diseases in rheumatic patients: facts and controversies.Specific Surface Modifications of Silica Nanoparticles Diminish Inflammasome Activation and In Vivo Expression of Selected Inflammatory Genes.Life-threatening rituximab-induced pyoderma gangrenosum successfully treated with intravenous immunoglobulin.
P2860
Involvement of NLRP3 inflammasome in rituximab-induced interstitial lung disease: a case report.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Involvement of NLRP3 inflammas ...... l lung disease: a case report.
@ast
Involvement of NLRP3 inflammas ...... l lung disease: a case report.
@en
type
label
Involvement of NLRP3 inflammas ...... l lung disease: a case report.
@ast
Involvement of NLRP3 inflammas ...... l lung disease: a case report.
@en
prefLabel
Involvement of NLRP3 inflammas ...... l lung disease: a case report.
@ast
Involvement of NLRP3 inflammas ...... l lung disease: a case report.
@en
P2093
P2860
P356
P1476
Involvement of NLRP3 inflammas ...... l lung disease: a case report.
@en
P2093
P2860
P304
P356
10.1111/JCPT.12198
P577
2014-08-16T00:00:00Z